164 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
the Amended and Restated Spyre 2023 Equity Incentive Plan. The Common Stock and the Series A Preferred Stock related to the Asset Acquisition were issued … options to purchase 2,734 shares of Common Stock from the Amended and Restated Spyre 2023 Equity Incentive Plan. On November 28, 2023, we changed our
424B3
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Prospectus supplement
4:06pm
compensation, excess benefit, profit-sharing, bonus, incentive, equity or equity-based, phantom equity, employment, consulting, severance, change … periodic report under the Exchange Act, other than pursuant to incentive awards issued under the Company’s incentive award plans, the issuance
8-K
EX-10.1
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
-sharing, bonus, incentive, equity or equity-based, phantom equity, employment, consulting, severance, change-of-control, retention, health, life … , other than pursuant to incentive awards issued under the Company’s incentive award plans, the issuance of shares of Common Stock to employees pursuant
POS AM
asoyvntp5b63jahm0
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
m7uiyf06qxgny ny
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
S-8
bdp 5m0g0w7i
29 Feb 24
Registration of securities for employees
5:06pm
S-8
v2q1wjvjmw1vvcwo3
29 Feb 24
Registration of securities for employees
5:06pm
S-8
EX-5.1
hvmxv6
29 Feb 24
Registration of securities for employees
5:06pm